Cargando…

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings

BACKGROUND: Medicines that are based on known molecules and are further developed to address healthcare needs and deliver relevant improvement for patients, healthcare professionals and/or payers are called value-added medicines (VAMs). The evaluation process of VAMs is heterogeneous across countrie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petykó, Zsuzsanna Ida, Kaló, Zoltán, Espin, Jaime, Podrazilová, Kateřina, Tesař, Tomáš, Maniadakis, Nikos, Fricke, Frank-Ulrich, Inotai, András
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406013/ https://www.ncbi.nlm.nih.gov/pubmed/34465350 http://dx.doi.org/10.1186/s12962-021-00311-6

Ejemplares similares

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
por: Kaló, Zoltán, et al.
Publicado: (2021)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018)

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
por: Inotai, András, et al.
Publicado: (2012)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2021)

Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts
por: Inotai, Andras, et al.
Publicado: (2018)

Proposal for capturing patient experience through extended value frameworks of health technologies
por: Inotai, András, et al.
Publicado: (2021)

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
por: McQueen, R. Brett, et al.
Publicado: (2022)

Potential Cost-Savings From the Use of the Biosimilars in Slovakia
por: Tesar, Tomas, et al.
Publicado: (2020)

Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
por: Incze, András, et al.
Publicado: (2022)

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
por: Zemplényi, Antal, et al.
Publicado: (2023)

How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia
por: Tesar, Tomas, et al.
Publicado: (2019)

Overview on Patient Centricity in Cancer Care
por: Narbutas, Šarunas, et al.
Publicado: (2017)

Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries
por: Inotai, András, et al.
Publicado: (2020)

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer
por: Tesar, Tomas, et al.
Publicado: (2017)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
por: Vokó, Zoltán, et al.
Publicado: (2012)

The EEC at the end of the seventies : Western European integration in the new world economic environment /
por: Inotai, András
Publicado: (1979)

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making
por: Németh, Bertalan, et al.
Publicado: (2023)

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
por: Jakab, Ivett, et al.
Publicado: (2023)

Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review
por: Ágh, Tamás, et al.
Publicado: (2015)

The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth.
por: Dejmek, Jan, et al.
Publicado: (2002)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
por: Kawalec, Paweł, et al.
Publicado: (2017)

Contribution of clinical trials to gross domestic product in Hungary
por: Kaló, Zoltán, et al.
Publicado: (2014)

Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; A telephone survey
por: Maniadakis, Nikos, et al.
Publicado: (2011)

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
por: Tachkov, Konstantin, et al.
Publicado: (2022)

Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries
por: Kovács, Sandor, et al.
Publicado: (2022)

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
por: Jakab, Ivett, et al.
Publicado: (2020)

Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries
por: Kaló, Zoltán, et al.
Publicado: (2020)

Somatostatin expressing GABAergic interneurons in the medial entorhinal cortex preferentially inhibit layer(III-V) pyramidal cells
por: Kecskés, Miklós, et al.
Publicado: (2020)

Cost transferability problems in economic evaluation as a framework for an European health care and social costs database
por: García-Mochón, Leticia, et al.
Publicado: (2021)

Pharmacoeconomic considerations in the treatment of breast cancer
por: Pallis, Athanasios, et al.
Publicado: (2010)

The disease burden of chronic obstructive pulmonary disease in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public Hospitals
por: Panagiotopoulos, Panos, et al.
Publicado: (2019)

Phylogenetic Core Groups: a promising concept in search of a consistent methodological framework: Comment to ``A conceptual framework for the phylogenetically-constrained assembly of microbial communities''
por: Pascual-García, Alberto
Publicado: (2021)

Adding multi-core support to the ALICE Grid Middleware
por: Weisz, Sergiu, et al.
Publicado: (2023)

Entity Framework Core in Action
por: Smith, Jon
Publicado: (2018)

Scalable Multi-core Architectures: Design Methodologies and Tools
por: Soudris, Dimitrios, et al.
Publicado: (2012)

Joint Use of e.Photoexpression(©) and Photonarration: What Methodological Added Value?
por: Maéliane, Deyra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0t9m0ltuhkhso0th5hj2s0kdr2